Tenderwize
Wróć do wyszukiwania

Open-house rebate agreement for epinephrine prefilled syringe/prefilled pen

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Sep 30, 2026 · 34 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darr. Fertigspritze/Fertigpen

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

Participation documents must be submitted via the DTVP communication function, but the notice says some portal instruct...

Only pharmaceutical companies within the meaning of § 4(18) AMG may participate for the offered medicinal products, and...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2026
  • Non-exclusive rebate agreements for epinephrine medicinal products in prefilled syringe/prefilled pen form, excluding 500 micrograms.
  • Open-House participation model with contracts available to all interested eligible pharmaceutical companies during the participation period.
Pokaż pełne podsumowanie

This is an Open-House supply arrangement for non-exclusive pharmaceutical rebate agreements under §130a(8) SGB V for epinephrine (ATC C01CA24) in prefilled syringe/prefilled pen form, excluding 500 micrograms. The lead buyer is AOK PLUS. Participation is open to all eligible pharmaceutical companies during the participation period, with no individual negotiations and no supply exclusivity. Submission is electronic via DTVP communication functions, but the notice says some portal instructions are technically misleading and the participation documents must be obtained from the project room. No contract value is stated.

Ryzyka

Participation documents must be submitted via the DTVP communication function, but the notice says some portal instruct...

Only pharmaceutical companies within the meaning of § 4(18) AMG may participate for the offered medicinal products, and...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical company within the meaning of § 4(18) AMG for the offered medicinal products.
  • The company must accept the participation requirements and the rebate agreement terms.

Administrative

  • An application for access to the project room is required before downloading the participation documents.

Zamawiający

Lokalizacja

Erfurt, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE256878834

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreement for epinephrine prefilled syringe/prefilled pen

Single lot covering non-exclusive rebate agreements for medicinal products with epinephrine (ATC C01CA24) in prefilled syringe/prefilled pen presentation, excluding 500 micrograms. The arrangement is an Open-House model with no exclusivity and no individual negotiations. Place of performance is Dresden, Germany, with performance geography stated as Germany, Saxony and Thuringia in the notice text.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Dresden, Germany

Czas trwania

Sep 2025 - Sep 2026

Kategoria

Pharmaceutical products

Termin

Deadline Sep 30, 2026

Szczegóły zamówienia

Data publikacji
31 Jul 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
504736-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3